Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.905 USD | +1.22% | +24.15% | +70.88% |
05-07 | Transcript : Heron Therapeutics, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Heron Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 147M 11.74B | Sales 2025 * | 178M 14.24B | Capitalization | 432M 34.6B |
---|---|---|---|---|---|
Net income 2024 * | -37M -2.96B | Net income 2025 * | -23M -1.84B | EV / Sales 2024 * | 2.95 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.43 x |
P/E ratio 2024 * |
-10.4
x | P/E ratio 2025 * |
-33.8
x | Employees | 126 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.31% |
Latest transcript on Heron Therapeutics, Inc.
1 day | +1.22% | ||
1 week | +24.15% | ||
Current month | +25.22% | ||
1 month | +5.64% | ||
3 months | +23.62% | ||
6 months | +304.54% | ||
Current year | +70.88% |
Managers | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 20/02/23 |
Ira Duarte
DFI | Director of Finance/CFO | 55 | 15/06/23 |
Chris Storgard
CTO | Chief Tech/Sci/R&D Officer | 58 | 31/10/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Craig Collard
CEO | Chief Executive Officer | 58 | 20/02/23 |
Susan Rodriguez
BRD | Director/Board Member | 60 | 19/09/21 |
Craig Johnson
BRD | Director/Board Member | 62 | 12/01/14 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | -.--% | - |
Date | Price | Change | Volume |
---|---|---|---|
08/05/24 | 2.905 | +1.22% | 992 901 |
07/05/24 | 2.87 | +1.06% | 7,054,505 |
06/05/24 | 2.84 | +8.81% | 3,138,270 |
03/05/24 | 2.61 | +2.35% | 1,342,099 |
02/05/24 | 2.55 | +8.97% | 1,501,408 |
Delayed Quote Nasdaq, May 08, 2024 at 04:38 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+70.88% | 432M | |
+23.12% | 46.4B | |
-1.62% | 41.75B | |
+48.83% | 41.37B | |
-3.42% | 29.71B | |
+9.86% | 26.01B | |
-19.11% | 19.52B | |
+30.32% | 12.43B | |
-0.36% | 12.18B | |
-0.66% | 12.13B |
- Stock Market
- Equities
- HRTX Stock